Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (30)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Maesaki, S.
Right arrow Articles by Kohno, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maesaki, S.
Right arrow Articles by Kohno, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy, Vol 42, 747-753, Copyright © 1998 by The British Society for Antimicrobial Chemotherapy

Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains [In Process Citation]

S Maesaki, P Marichal, MA Hossain, D Sanglard, H Vanden Bossche and S Kohno
The Second Department of Internal Medicine, Nagasaki University School of Medicine, Japan.

We investigated the effects of combining tacrolimus and azole antifungal agents in azole-resistant strains of Candida albicans by comparing the accumulation of [3H]itraconazole. The CDR1-expressing resistant strain C26 accumulated less itraconazole than the CaMDR- expressing resistant strain C40 or the azole-sensitive strain B2630. A CDR1-expressing Saccharomyces cerevisiae mutant, DSY415, showed a marked reduction in the accumulation of both fluconazole and itraconazole. A CaMDR-expressing S. cerevisiae mutant, DSY416, also showed lower accumulation of fluconazole, but not of itraconazole. The addition of sodium azide, an electron-transport chain inhibitor, increased the intracellular accumulation of itraconazole only in the C26 strain, and not in the C40 or B2630 strains. Addition of tacrolimus, an inhibitor of multidrug resistance proteins, resulted in the highest increase in itraconazole accumulation in the C26 strain. The combination of itraconazole and tacrolimus was synergic in azole- resistant C. albicans strains. In the C26 strain, the MIC of itraconazole decreased from >8 to 0.5 mg/L when combined with tacrolimus. Our results showed that two multidrug resistance phenotypes (encoded by the CDR1 and CaMDR genes) in C. albicans have different substrate specificity for azole antifungal agents and that a combination of tacrolimus and azole antifungal agents is effective against azole-resistant strains of C. albicans.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
E. Dannaoui, P. Schwarz, and O. Lortholary
In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes
Antimicrob. Agents Chemother., August 1, 2009; 53(8): 3549 - 3551.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
S. Mehta, H. Li, P. G. Hogan, and K. W. Cunningham
Domain Architecture of the Regulators of Calcineurin (RCANs) and Identification of a Divergent RCAN in Yeast
Mol. Cell. Biol., May 15, 2009; 29(10): 2777 - 2793.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. Sun, Y. Li, Q. Guo, C. Shi, J. Yu, and L. Ma
In Vitro Interactions between Tacrolimus and Azoles against Candida albicans Determined by Different Methods
Antimicrob. Agents Chemother., February 1, 2008; 52(2): 409 - 417.
[Abstract] [Full Text] [PDF]

Home page
 Eukaryot CellHome page
E. Lamping, B. C. Monk, K. Niimi, A. R. Holmes, S. Tsao, K. Tanabe, M. Niimi, Y. Uehara, and R. D. Cannon
Characterization of Three Classes of Membrane Proteins Involved in Fungal Azole Resistance by Functional Hyperexpression in Saccharomyces cerevisiae
Eukaryot. Cell, July 1, 2007; 6(7): 1150 - 1165.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
J. R. Blankenship and J. Heitman
Calcineurin Is Required for Candida albicans To Survive Calcium Stress in Serum
Infect. Immun., September 1, 2005; 73(9): 5767 - 5774.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
P. Saini, T. Prasad, N. A. Gaur, S. Shukla, S. Jha, S. S. Komath, L. A. Khan, Q. Mohd. R. Haq, and R. Prasad
Alanine scanning of transmembrane helix 11 of Cdr1p ABC antifungal efflux pump of Candida albicans: identification of amino acid residues critical for drug efflux
J. Antimicrob. Chemother., July 1, 2005; 56(1): 77 - 86.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
T. Sugita, M. Tajima, T. Ito, M. Saito, R. Tsuboi, and A. Nishikawa
Antifungal Activities of Tacrolimus and Azole Agents against the Eleven Currently Accepted Malassezia Species
J. Clin. Microbiol., June 1, 2005; 43(6): 2824 - 2829.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
W. J. Steinbach, N. Singh, J. L. Miller, D. K. Benjamin Jr., W. A. Schell, J. Heitman, and J. R. Perfect
In Vitro Interactions between Antifungals and Immunosuppressants against Aspergillus fumigatus Isolates from Transplant and Nontransplant Patients
Antimicrob. Agents Chemother., December 1, 2004; 48(12): 4922 - 4925.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
R. C. Pascon, T. M. Ganous, J. M. Kingsbury, G. M. Cox, and J. H. McCusker
Cryptococcus neoformans methionine synthase: expression analysis and requirement for virulence
Microbiology, September 1, 2004; 150(9): 3013 - 3023.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
S. Shukla, S. V. Ambudkar, and R. Prasad
Substitution of threonine-1351 in the multidrug transporter Cdr1p of Candida albicans results in hypersusceptibility to antifungal agents and threonine-1351 is essential for synergic effects of calcineurin inhibitor FK520
J. Antimicrob. Chemother., July 1, 2004; 54(1): 38 - 45.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
W. J. Steinbach, W. A. Schell, J. R. Blankenship, C. Onyewu, J. Heitman, and J. R. Perfect
In Vitro Interactions between Antifungals and Immunosuppressants against Aspergillus fumigatus
Antimicrob. Agents Chemother., May 1, 2004; 48(5): 1664 - 1669.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
K. Niimi, D. R. K. Harding, R. Parshot, A. King, D. J. Lun, A. Decottignies, M. Niimi, S. Lin, R. D. Cannon, A. Goffeau, et al.
Chemosensitization of Fluconazole Resistance in Saccharomyces cerevisiae and Pathogenic Fungi by a D-Octapeptide Derivative
Antimicrob. Agents Chemother., April 1, 2004; 48(4): 1256 - 1271.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J. Afeltra, R. G. Vitale, J. W. Mouton, and P. E. Verweij
Potent Synergistic In Vitro Interaction between Nonantimicrobial Membrane-Active Compounds and Itraconazole against Clinical Isolates of Aspergillus fumigatus Resistant to Itraconazole
Antimicrob. Agents Chemother., April 1, 2004; 48(4): 1335 - 1343.
[Abstract] [Full Text] [PDF]

Home page
 Eukaryot CellHome page
J. R. Blankenship, F. L. Wormley, M. K. Boyce, W. A. Schell, S. G. Filler, J. R. Perfect, and J. Heitman
Calcineurin Is Essential for Candida albicans Survival in Serum and Virulence
Eukaryot. Cell, June 1, 2003; 2(3): 422 - 430.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
C. Gauthier, S. Weber, A.-M. Alarco, O. Alqawi, R. Daoud, E. Georges, and M. Raymond
Functional Similarities and Differences between Candida albicans Cdr1p and Cdr2p Transporters
Antimicrob. Agents Chemother., May 1, 2003; 47(5): 1543 - 1554.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
C. Onyewu, J. R. Blankenship, M. Del Poeta, and J. Heitman
Ergosterol Biosynthesis Inhibitors Become Fungicidal when Combined with Calcineurin Inhibitors against Candida albicans, Candida glabrata, and Candida krusei
Antimicrob. Agents Chemother., March 1, 2003; 47(3): 956 - 964.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. Maesaki, M. A. Hossain, Y. Miyazaki, K. Tomono, T. Tashiro, and S. Kohno
Efficacy of FK463, a (1,3)-beta -D-Glucan Synthase Inhibitor, in Disseminated Azole-Resistant Candida albicans Infection in Mice
Antimicrob. Agents Chemother., June 1, 2000; 44(6): 1728 - 1730.
[Abstract] [Full Text]

Home page
 Antimicrob. Agents Chemother.Home page
M. Del Poeta, M. C. Cruz, M. E. Cardenas, J. R. Perfect, and J. Heitman
Synergistic Antifungal Activities of Bafilomycin A1, Fluconazole, and the Pneumocandin MK-0991/Caspofungin Acetate (L-743,873) with Calcineurin Inhibitors FK506 and L-685,818 against Cryptococcus neoformans
Antimicrob. Agents Chemother., March 1, 2000; 44(3): 739 - 746.
[Abstract] [Full Text]

Home page
 J Antimicrob ChemotherHome page
S. Maesaki, P. Marichal, H. V. Bossche, D. Sanglard, and S. Kohno
Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains
J. Antimicrob. Chemother., July 1, 1999; 44(1): 27 - 31.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.